London Biotechnology Show 2024 is a highly anticipated event scheduled for May 8th and 9th at Olympia West. The event is...
After joining forces in a $12.3 billion merger, Denmark headquartered bioscience companies Novozymes and Chr. Hansen hav...
Swedish firm BioArctic AB's partner Eisai has announced that LEQEMBI (lecanemab) will be launched in Japan&nbs...
India-based Bharat Biotech International and the University of Sydney Infectious Diseases Institute (Sydney ID) have ann...
The Ministry of Health and Welfare of South Korea government recently held the ‘K-Bio Investment Conference&r...
World-renowned professors from six leading institutions in four countries have launched the Pandemic Research Allia...
Merck, a leading science and technology company, has launched its AIDDISON™ drug discovery software, the firs...
GC Biopharma, a South Korean biopharmaceutical company, has announced that it has participated in the groundbreaking cer...
Singapore General Hospital (SGH) patients are expected to benefit from healthcare innovations, such as customised medica...
Taiwan Bio and US-based TRACT Therapeutics have announced new strategic partnership to advance a cellular therapy t...
Apart from the generative AI which many of us are using nowadays to assist many of our daily tasks, there are also other...
CytoMed Therapeutics, a Singapore-based biopharmaceutical company focused on harnessing its proprietary technologies to ...
GC Biopharma, a South Korean biopharmaceutical company, has completed the construction mRNA (messenger ribonucleic acid)...
US-based Cerecin Inc., has signed a Memorandum of Understanding (MoU) with Singapore-based A*STAR's Institute of Molecul...
Japan-based PRISM BioLab, a leading discovery and development biotechnology company designing small molecule inhibitors ...
Akeso, a China-based biopharmaceutical company, has announced the establishment of the Akeso Global R&D Centre....
The Coalition for Epidemic Preparedness Innovations (CEPI), the Republic of Korea-based International Vaccine Institute ...
China Volume-Based Procurement (VBP) Policy In 2018, China introduced VBP for pharmaceuticals, as an attempt to reduce ...
Asia’s life sciences industry has not been immune to the headwinds and uncertainties. For most sectors, ranging fr...
In the Asia-Pacific region, we see two key strategic trends within Policy, Access, Value, and Evidence: Continuing and ...
2023 was the year when the world finally emerged from the grips of COVID-19. The biopharma industry looked beyond the pa...
In March 2023, Pfizer announced a $43 billion merger with Seagen, one of the most substantial M&A deals in recent ti...
A number of Memoranda of Understanding (MoU) on advanced biotechnology cooperation in the fields of synthetic biology, b...
Australia-based Monash University and India’s Amity University have signed a Memorandum of Understanding (MoU) to ...
The symposium is a heartfelt gesture of gratitude and appreciation to Singapore's vibrant Bioscience community, followin...
